Product Information
CHILD'S MULTI-SYMPTOM COLD LIQ is a generic product labeled by Cardinal Health, priced at $0.0468 per ML under NDC 70000062901. Its NADAC has been published 138 times since Feb 14, 2024.
Strength
5; 100; 2.5 mg/5mL; mg/5mL; mg/5mL
Manufacturer
Cardinal HealthNDC
70000062901
Classification
Generic
Dosage Form
LIQUID
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDEApproval Type
OTC MONOGRAPH DRUG
FDA Application
M012On Market Since
3/15/2023
Pharmacological Classes
Price Statistics
The NADAC for CHILD'S MULTI-SYMPTOM COLD LIQ has been published 138 times since Feb 14, 2024, and over the history we have for it it has risen 70.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0468 per ML |
|---|---|
| All-time high | $0.0469 (Mar 11, 2026) |
| All-time low | $0.0225 (May 22, 2024) |
| 52-week high | $0.0469 |
| 52-week low | $0.0418 |
| Median price | $0.0368 |
| Average price | $0.0371 |
| Largest weekly change | +16.0% (Nov 20, 2024) |
| Weeks tracked | 138 |
| Tracking since | Feb 14, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Dextromethorphan HBr, guaifenesin, Phenylephrine HCl market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Cardinal Health manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Dextromethorphan HBr, guaifenesin, Phenylephrine HCl market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Expectorant class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CHILD'S MULTI-SYMPTOM COLD LIQ?
The current National Average Drug Acquisition Cost (NADAC) for CHILD'S MULTI-SYMPTOM COLD LIQ, manufactured by Cardinal Health, is $0.0468 per ML (NDC 70000062901), effective Sep 30, 2026.
How has the price of CHILD'S MULTI-SYMPTOM COLD LIQ changed over time?
Over the history we have for it, the NADAC for CHILD'S MULTI-SYMPTOM COLD LIQ has risen 70.8%. It has been tracked across 138 weekly CMS publications since Feb 14, 2024.
What are the highest and lowest recorded NADAC prices for CHILD'S MULTI-SYMPTOM COLD LIQ?
Since Feb 14, 2024, the NADAC for CHILD'S MULTI-SYMPTOM COLD LIQ has ranged from a low of $0.0225 (May 22, 2024) to a high of $0.0469 (Mar 11, 2026), with a median of $0.0368 per ML.
Are there cheaper alternatives to CHILD'S MULTI-SYMPTOM COLD LIQ?
No other NADAC-published product currently shares the active ingredient and strength of CHILD'S MULTI-SYMPTOM COLD LIQ in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures CHILD'S MULTI-SYMPTOM COLD LIQ?
CHILD'S MULTI-SYMPTOM COLD LIQ (NDC 70000062901) is labeled by Cardinal Health, and CMS classifies it as a generic product.